XOFIGO ® (radium-223 dichloride) in combination with enzalutamide significantly increased radiological progression-free survival (rPFS) for patients with metastatic castration-resistant prostate ...
Bushcraft Base Camp on MSNOpinion
How .223 and 5.56 Became the Most Misunderstood Cartridges
Why .223 and 5.56 remain widely misunderstood. The post How .223 and 5.56 Became the Most Misunderstood Cartridges appeared ...
New data from the Phase III PEACE III trial showed that XOFIGO ® (radium-223 dichloride) in combination with enzalutamide significantly improved prostate-specific antigen (PSA) response rates (≥90% at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback